Adamis Pharma Price on July 19, 2023

ADMPDelisted Stock  USD 1.74  0.24  12.12%   
If you're considering investing in Adamis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Adamis Pharma stands at 1.74, as last reported on the 1st of December, with the highest price reaching 1.99 and the lowest price hitting 1.67 during the day. We have found twenty-three technical indicators for Adamis Pharma, which you can use to evaluate the volatility of the firm. Please confirm Adamis Pharma's risk adjusted performance of (0.19), and Mean Deviation of 4.75 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Adamis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ADMP
Based on monthly moving average Adamis Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adamis Pharma by adding Adamis Pharma to a well-diversified portfolio.

Related Headline

Mallinckrodt Plc Headline on 19th of July 2023

NEW YORK, July 19, 2023 Pomerantz LLP announces that a class action lawsuit has been filed against Mallinckrodt plc , and certain officers. The class

Adamis Pharma Valuation on July 19, 2023

It is possible to determine the worth of Adamis Pharma on a given historical date. On July 19, 2023 Adamis was worth 2.03 at the beginning of the trading date compared to the closed value of 2.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Adamis Pharma stock. Still, in general, we apply an absolute valuation method to find Adamis Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Adamis Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Adamis Pharma's related companies.
 Open High Low Close Volume
  2.02    2.12    2.01    2.05    37,920  
07/19/2023
  2.03    2.09    1.97    2.00    58,319  
  1.99    2.04    1.92    2.01    76,491  
Backtest Adamis Pharma  |  Adamis Pharma History  |  Adamis Pharma Valuation   PreviousNext  
Open Value
2.03
2.0
Closing Value
2.03
Upside

Adamis Pharma Trading Date Momentum on July 19, 2023

On July 20 2023 Adamis Pharma was traded for  2.01  at the closing time. The top price for the day was 2.04  and the lowest listed price was  1.92 . The trading volume for the day was 76.5 K. The trading history from July 20, 2023 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 0.50% . The overall trading delta against the current closing price is 1.00% .

Adamis Pharma Fundamentals Correlations and Trends

By evaluating Adamis Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Adamis Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Adamis financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Adamis Pharma Stock history

Adamis Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Adamis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Adamis Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Adamis Pharma stock prices may prove useful in developing a viable investing in Adamis Pharma
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California. Adamis Pharmaceuticl operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.

Adamis Pharma Stock Technical Analysis

Adamis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Adamis Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Adamis Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Adamis Pharma Period Price Range

Low
December 1, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Adamis Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Adamis Pharma December 1, 2024 Market Strength

Market strength indicators help investors to evaluate how Adamis Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Adamis Pharma shares will generate the highest return on investment. By undertsting and applying Adamis Pharma stock market strength indicators, traders can identify Adamis Pharma entry and exit signals to maximize returns

Adamis Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Adamis Pharma's price direction in advance. Along with the technical and fundamental analysis of Adamis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Adamis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Adamis Stock

If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas